We are delighted to announce that emotive will be the sole medical and scientific communications Exhibition Partner at this year’s Gene Therapy for Rare Disorders conference taking place in Boston, Massachusetts from March 30th to April 2nd.
Now in its fourth year, this important event will focus on how drug developers can learn from each other, overcome CMC, clinical and commercial challenges and realise the potential of gene therapies.
Already working with several pre and post-launch advanced therapies, emotive has built significant expertise in this rapidly evolving and potentially transformative field of medicine. Working alongside its market access and market research partners, Initiate and Genactis, emotive supports ATMP biopharma companies and those serving rare disorder communities at all stages of the product lifecycle by creating engaging communications with HCPs and others in the care pathway.
If you would like to know more about how emotive and its partners can help you truly engage your audience, do come and find us in the Exhibition Hall or arrange a meeting by emailing Anjani Patel on firstname.lastname@example.org.